RBC Capital lowered the firm’s price target on Jack Henry (JKHY) to $180 from $210 and keeps an Outperform rating on the shares. The company delivered solid Q3 results but the firm believes the implied Q4 revenue deceleration is weighing on shares, the analyst tells investors in a research note. Q4 margins are also expected to be pressured by medical costs returning to normalized levels, higher cloud migration infrastructure costs, commission timing, and unfavorable product mix, the firm added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JKHY:
